We are live on ! Find out more
JHMH

John Hancock Multifactor Healthcare ETF

Delisted

JHMH was delisted on the 24th of October, 2022.

24 hedge funds and large institutions have $28.2M invested in John Hancock Multifactor Healthcare ETF in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

4% more funds holding

Funds holding: 2324 (+1)

2% less capital invested

Capital invested by funds: $28.7M → $28.2M (-$455K)

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

Holders
24
Holders Change
+1
Holders Change %
+4.35%
% of All Funds
0.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
7
Reduced
8
Closed
4
Calls
Puts
Net Calls
Net Calls Change

JHMH Hedge Fund Activity: Q2 2022 in Review

24 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in John Hancock Multifactor Healthcare ETF (JHMH) for Q2 2022, worth a combined $28.2M — down 1.6% from $28.7M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new JHMH positions and 4 closed out — a net gain of 1 holder — while 7 added to existing stakes and 8 trimmed.

The largest buyer was Raymond James Financial Services Advisors, adding an estimated $628K. The largest seller was Commonwealth Equity Services, cutting an estimated $475K.

  • 24 institutional investors held John Hancock Multifactor Healthcare ETF (JHMH) as of Q2 2022, up from 23 in Q1 2022.
  • Funds reported $28.2M of John Hancock Multifactor Healthcare ETF stock for Q2 2022, down 1.6% quarter-over-quarter.
  • 5 funds opened new John Hancock Multifactor Healthcare ETF positions in Q2 2022 and 4 closed out, a net change of +1 holder.
  • The largest John Hancock Multifactor Healthcare ETF buyer in Q2 2022 was Raymond James Financial Services Advisors, an estimated $628K added.
  • The largest John Hancock Multifactor Healthcare ETF seller in Q2 2022 was Commonwealth Equity Services, an estimated $475K sold.

Based on aggregated 13F filings for Q2 2022.